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Exacerbated activation of glutamate receptor-coupled calcium channels and subsequent increase in intracellular calcium
([Ca
2þ]i) are established hallmarks of neuronal cell death in acute and chronic neurological diseases. Here we show that
pathological [Ca
2þ]i deregulation occurring after glutamate receptor stimulation is effectively modulated by small conductance
calcium-activated potassium (KCa2)channels. We found that neuronal excitotoxicity was associated with a rapid downregulation
of KCa2.2 channels within 3h after the onset of glutamate exposure. Activation of KCa2 channels preserved KCa2 expression and
signiﬁcantly reducedpathologicalincreasesin[Ca
2þ]iprovidingrobustneuroprotectioninvitroandinvivo.Thesedatasuggest
a critical role for KCa2 channels in excitotoxic neuronal cell death and propose their activation as potential therapeutic strategy
for the treatment of acute and chronic neurodegenerative disorders.
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Excessive release of glutamate and uncontrolled neuronal
excitations lead to progressive neuronal death following
cerebral ischemia. In particular, glutamate-induced stimula-
tion of a-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid
and N-methyl-D-aspartate (NMDA) receptors mediates toxic
increases in intracellular calcium concentrations ([Ca
2þ]i). In
neurons, disrupted intracellular calcium homeostasis disturbs
multiple metabolic processes thereby promoting progressive
celldeath.
1–3Consequently,inhibitionofNMDA receptorshas
been extensively investigated in experimental and clinical
stroke studies. For example, studies on NMDA receptor
antagonists such as dizocilpine (MK-801) or memantine
revealed neuroprotective effects against ischemia-induced
neuronal death in vitro and ischemic brain damage in vivo,
4,5
promoting disturbed [Ca
2þ]i as a promising therapeutic
target. However, inhibitors of NMDA receptors largely failed
in clinical studies
6 and, therefore, novel strategies controlling
[Ca
2þ]i homeostasis are warranted for the development of
effective therapies of neurological disorders associated with
excessive NMDA receptor stimulation.
It has been suggested that small-conductance calcium-
activated potassium (KCNN/SK/KCa2) channels may control
membrane excitability through attenuated NMDA receptor
activity.
7,8 In neurons, synaptic NMDA receptors are closely
associated with KCa2 channels in dendritic spines. Small
increases in [Ca
2þ]i lead to the activation of KCa2 channels,
which induce afterhyperpolarization thereby providing a
feedback control that prevents toxic increases in [Ca
2þ]i
under physiological conditions.
9
How KCa2 channel-dependent [Ca
2þ]i regulation is altered
under pathological conditions, in which glutamate toxicity has
an essential role, is so far unknown. Thus, we address the
question whether pharmacological modulation of KCa2 chan-
nels attenuates glutamate-induced [Ca
2þ]i deregulation and
cell death in primary cultured neurons in vitro and reduces
infarct size following cerebral ischemia in vivo.
Results
Activation of KCa2 channels prevents the increases in
[Ca
2þ]i after glutamate exposure in neurons. Glutamate
immediately induced increases in ﬂuorescence intensities of
the calcium-sensitive dye FURA-2 and these increases in
[Ca
2þ]i over control levels sustained until termination of the
measurements (Figure 1a). These glutamate-induced
alterations in [Ca
2þ]i signals can be subdivided into three
phases: an early phase was detected as a very fast and
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www.nature.com/cddisFigure1 EffectofKCa2channelmodulatorsontheonsetofglutamate-induceddelayedcalciumderegulation.(a)NeuronalcellswereloadedwithFURA-2AMandthenstimulated
with glutamate (20mM) in the presence or absence of NS309 (50mM), NS8593 (50mM) or apamin (1mM) pre-treatment. Glutamate was applied to neurons after monitoring the cells
for 1min, as shown in the [Ca
2þ]i kinetic proﬁle. (a) Representative FURA-2 ﬂuorescence intensities from neurons stimulated with glutamate (at 1min) in the presence of NS309,
NS8593 or apamin. (b–d) Depicted are representative traces of [Ca
2þ]i FURA-ratios values (±S.E.M.) stimulated with glutamate in the presence of the indicated KCa2 channel
modulators (n¼15–25). (e) MTT analysis of primary neuronal cultures pre-treated with NS309 (50mM) or apamin (10mM) and challenged with glutamate (20mM) for 24h
(**Po0.01 versus glutamate-treated neurons, ANOVA, Scheffe ´’s test)
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Cell Death and Diseasepronounced increase in [Ca
2þ]i followed by a second phase
with a short decrease of [Ca
2þ]i, and a third phase
characterized by a sustained [Ca
2þ]i increase that showed
a higher amplitude than the early phase (Figure 1b). The
length of the second phase varied in range from seconds to
minutes in different experimental settings. Moreover,
individual neurons show this intermediate decrease of
[Ca
2þ]i at different time intervals ranging from 3 to 4min
up to 10min, which limits the detection of this proposed
second phase in average Ca
2þ kinetics plotted from up to 25
neurons. The third phase of the Ca
2þ kinetic is regarded as
‘delayed calcium deregulation’ (DCD), which contributes to
delayed cellular death.
1,10 DCD was detected for periods of
up to 1–2h (Supplementary Figure S1A). Measurements of
[Ca
2þ]i in cortical neurons did not show any spontaneous
[Ca
2þ]i spikes in both basal conditions or in glutamate-
stimulated neurons. This was further demonstrated by
application of tetrodotoxin (TTX), which is known to block
the transient spontaneous [Ca
2þ]i spikes. TTX failed to
inﬂuence DCD formation (Supplementary Figure S1B). This
ﬁnding is consistent with other reports that founds that TTX
does not block DCD formation
1 and also does not prevent the
delayed cell death.
11
Single-cell ﬂuorescence imaging further revealed that pre-
treatment of neurons with NS309, an activator of KCa2
channels,
12 prevented increases in [Ca
2þ]i, and signiﬁcantly
reducedDCD (Figure 1).Whole-culture[Ca
2þ]irecordings for
more than 1h conﬁrmed that the KCa2 channel activator
NS309 attenuated the glutamate-induced elevated levels of
[Ca
2þ]i similar to the observations obtained by single-cell
imaging (Supplementary Figure S1A).
In contrast to the ﬁndings with the KCa2 activator NS309,
pharmacological inhibition of KCa2 channels with NS8593
further increased the glutamate-induced increases in [Ca
2þ]i
levels in the DCD phase (Figures 1a and b). As NS8593
is a negative modulator for all KCa2 channels,
10 we used the
highly speciﬁc KCa2.2 channel blocker apamin. In line with
ﬁndings obtained with NS8593, apamin also promoted a
further increase in [Ca
2þ]i compared with the glutamate
challenge alone (Figure 1c). Moreover, pre-incubation
with apamin reduced the effect of NS309 on [Ca
2þ]i
(Figure 1d).
PreviousstudiesestablishedNS309 asa potent activatorof
recombinant KCa2 channels that induces an increase of the
IAHPinhippocampalbrainslices.
12Herewetestedtheeffectof
NS309 (50mM) on IAHP in CA1 neurons from 17- to 21-day-old
mice. Before NS309 application, the depolarization step
induced a characteristic IAHP. NS309 induced an increase of
IAHP in all cells tested (six of six cells; Supplementary
Figure S2). That was detectable even if the activator was
removed from the bath (Supplementary Figure S2).
To further strengthen the direct action of KCa2 channels on
calcium signaling, we investigated whether other potassium
channels might affect calcium homeostasis. To this end, we
applied diazoxide, a speciﬁc activator of KATP channels. Pre-
treatment and also post-treatment with diazoxide did not
affect glutamate-induced DCD, suggesting that KATP chan-
nels do not have a direct effect on DCD signaling. In addition,
inhibition of KATP channels with glibenclamide did not
signiﬁcantly alter the DCD (Supplementary Figure S3).
As KCa2 channel activation reduced [Ca
2þ]i after excessive
stimulation of glutamate receptors in neurons, we next
investigated whether KCa2 channel activation provided
neuroprotective effects against glutamate-induced excitotoxi-
city. Activation of KCa2 channels by NS309 signiﬁcantly
reduced glutamate toxicity (Figure 1e). In contrast, when
primary cortical neurons were subjected to toxic doses of
glutamate in the presence of the KCa2.2 channel blocker
apamin, neuronal cells were not rescued (Figure 1e). Further,
apamin also attenuated NS309-induced neuronal survival
indicating that neuroprotection by NS309 was mediated
through KCa2.2 channel activation (Figure 1e). Although
NS8593 (50mM) in combination with the glutamate challenge
resulted in a further increase in DCD mean values compared
with DCD induced by glutamate alone, NS8593 failed to show
a further induction of apoptotic markers, such as caspase 3
activation(SupplementaryFigureS3).Asapositivecontrolfor
a complete induction of cellular death we used ionomycin at
different concentrations (Figure 1e). Notably, NS309 failed to
promote cellular survival against glutamate toxicity when
KCa2.2 channels were downregulated by siRNA, conﬁrming
the particular role of this subtype as previously demonstrated
by pharmacological compounds (Supplementary Figure S4).
Overall, these ﬁndings strongly suggest that KCa2 channel
activity was critical for the maintenance of intracellular Ca
2þ
homeostasis and protection against glutamate-induced
excitotoxicity in primary neurons.
Modulation of KCa2 channels during deregulated Ca
2þ
homeostasis. To assess the effectiveness of KCa2 channel
modulators on regulating glutamate-induced [Ca
2þ]i
deregulation, we also applied NS309 and NS8593 after the
onset of the glutamate challenge. When NS309 was applied
to neurons after the onset of the early peak of [Ca
2þ]i,a
signiﬁcant recovery of [Ca
2þ]i was observed (Figures 2a
and b). NS309 reduced [Ca
2þ]i by B75% in the ﬁrst minute
and by B90% after 5min. In contrast, inhibition of KCa2
channels by NS8593 further elevated [Ca
2þ]i by 30% in the
ﬁrst 5min and by 60% after 10min (Figure 2b).
As demonstrated by 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide (MTT) assays, NS309 unequivo-
cally protected the neurons against glutamate toxicity when
applied before and up to 3h after the onset of a glutamate
challenge, in line with the restoration of calcium homeostasis
(Figure 2c).
KCa2 channels reduce the Ca
2þ inﬂux from the
extracellular space. Although NS309 completely restored
[Ca
2þ]i when applied in the ﬁrst minutes after onset of
glutamate exposure (Figures 2b and 3a), NS309 only
partially attenuated the DCD when applied during the late
phase of increased [Ca
2þ]i (Figure 3b). The remaining
question of why KCa2 channel activation failed to completely
recover [Ca
2þ]i applied after the onset of DCD prompted
us to investigate the sources of [Ca
2þ]i increases. To this
end, ethylene glycol tetraacetic acid (EGTA) or
ethylenediaminetetraacetic acid (EDTA; 4mM) were applied
to complex extracellular [Ca
2þ]. Under these conditions,
glutamate neither increased [Ca
2þ]i nor induced DCD
(Figure 3c), suggesting that extracellular Ca
2þ was
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Cell Death and Diseaserequired for [Ca
2þ]i deregulation. Complete removal of
external Ca
2þ during the early glutamate-induced [Ca
2þ]i
peak led to a fast [Ca
2þ]i recovery (Figures 3d and f).
However, when extracellular Ca
2þ was depleted with EDTA
after the onset of DCD, [Ca
2þ]i recovery was delayed and
incomplete (Figure 3g). The low-sensitivity of DCD to
extracellular Ca
2þ removal was similar to the previously
observed failure of NS309 to completely restore the [Ca
2þ]i
at late time points. The remaining [Ca
2þ]i could be a result of
delayed Ca
2þ release from intracellular stores from the
Figure 2 Effect of KCa2 channel modulators after the onset of glutamate-induced delayed calcium deregulation. (a) Representative FURA-2 ﬂuorescence intensities from
singlecells stimulatedwith 20mM glutamate (at 1min). NS309 (50mM) or NS8593 (50mM) were applied at 4min after onset of the glutamate challenge. (b) Kinetic proﬁles of
[Ca
2þ]i values (±S.E.M.) stimulated with glutamate (20mM) and then treated with NS309 (50mM), NS8593 (50mM) at the indicated time (n¼15–20). (c) DAPI counting of
neurons challenged with glutamate (20mM) in the presence or absence of NS309 (50mM) applied as indicated (*Po0.05, **Po0.01 versus glutamate-treated neurons,
ANOVA Scheffe ´’s test)
KCa2 channels regulate calcium homeostasis
AM Dolga et al
4
Cell Death and Diseaseendoplasmic reticulum (ER). To deplete Ca
2þ from ER
stores and to block sarco/ER Ca
2þ-ATPase (SERCA)
pumps, we applied thapsigargin and 2,5-di-t-butyl-1,4-
benzohydroquinone (BHQ). High concentrations of
thapsigargin (100mM) mediated very small [Ca
2þ]i
increases followed by complete [Ca
2þ]i recovery within
10min (Supplementary Figure S5A). Pre-treatment with
thapsigargin did not inﬂuence the glutamate-induced
[Ca
2þ]i deregulation (Figure 3h However, when KCa2
channels were activated after the onset of DCD, 100mM
thapsigargin completely blocked the protective effect of
NS309 on [Ca
2þ]i (Figure 3i). Thapsigargin and BHQ at
lower concentrations (10 and 25mM, respectively) only
partially blocked the KCa2 channel-mediated rescue of
[Ca
2þ]i (Supplementary Figure S5B). Altogether, these
ﬁndings suggest that the remaining delayed increases in
[Ca
2þ]i were attributed to extracellular and intracellular
sources.
Activation of KCa2 channels attenuates NMDA-induced
[Ca
2þ]i deregulation. Glutamate-induced increases in
[Ca
2þ]i through the NMDA receptor has a dominant role
in [Ca
2þ]i deregulation and in neuronal death.
10,13 In primary
neurons, NMDA increased [Ca
2þ]i and shaped the Ca
2þ
kinetics in a similar manner as glutamate (Supplementary
Figure S6A). Pre-treatment with the NMDA antagonist
MK801 attenuated the magnitude of the early glutamate-
induced [Ca
2þ]i peak and prevented the onset of DCD
(Supplementary Figure S6B). In addition, MK801 partially
restored [Ca
2þ]i levels when added after the onset of
NMDA-induced DCD (Supplementary Figure S6C). These
data supported the conclusion that the initial increase in
[Ca
2þ]i was mediated by NMDAR stimulation, whereas
the following DCD was mediated by additional sources of
Ca
2þ. Activation of KCa2 channels by NS309 resulted in a
complete recovery of [Ca
2þ]i when applied before NMDA-
induced [Ca
2þ]i deregulation (Supplementary Figure S6A).
However, NS309 only partially restored [Ca
2þ]i when applied
after the onset of NMDA-induced DCD (Supplementary
Figure S6D). Moreover, MTT analysis revealed that pre-
treatment with NS309 rescued primary neurons from NMDA-
induced neuronal death, suggesting that KCa2 channels
affected NMDA receptor activity and attenuated NMDA-
mediated excitotoxicity (Supplementary Figure S6E).
Figure 3 Depletion of extracellular Ca
2þ prevents the formation of delayed calcium deregulation (DCD). Neuronal cells were loaded with FURA-2 and then stimulated
with glutamate (20mM). The KCa2 channel activator (50mM NS309), or EGTA (4mM) were applied to neurons 2min (a) or 9–12min (c) after exposure to glutamate. The
inﬂuences of NS309 (a, b, f–i), EDTA (c, f and g)a n dE G T A(d and e) on the kinetic proﬁle of [Ca
2þ]i were evaluated prior and after the onset of DCD. Depicted are the kinetic
proﬁles of [Ca
2þ]i (±S.E.M.; n¼15–20). (h and i) The depletion of ER intracellular Ca
2þ pool was achieved with 100mM thapsigargin prior to or after the onset of DCD
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Cell Death and DiseaseGlutamate neurotoxicity is associated with reduced KCa2
channel protein levels. To gain further insight into the
relation between glutamate toxicity and KCa2 channel-
mediated [Ca
2þ]i regulation, we next investigated the
expression levels of KCa2 channels after the glutamate
challenge. Glutamate reduced the protein levels of KCa2.2
channels in a time-dependent manner (Figure 4a). These
results suggested that the observed DCD after glutamate
receptor stimulation and the failure of NS309 to rescue
[Ca
2þ]i levels when applied with delay was at least in part
attributed to KCa2 channel degradation. In fact, the KCa2
channel activator NS309 prevented the glutamate-induced
decrease in KCa2.2 channel expression (Figure 4b) and
NS309 protected neurons against glutamate toxicity when
applied up to 3h after the onset of glutamate challenge,
which was perfectly in line with the observed protein
expression levels of KCa2.2 channels (Figure 4c). Further,
EDTA application was able to block glutamate-induced
KCa2.2 channel downregulation, suggesting that increased
[Ca
2þ]i mediated this effect (Supplementary Figure S7A). On
the other hand, increase in [Ca
2þ]i can activate Ca
2þ-
dependent genes, which could control the expression of
KCa2.2 channels. Interestingly, short application of the
selective glutamate receptor agonist NMDA induced an
upregulation of KCa2.2 channel protein levels in the long
term (Supplementary Figure S7B). This was potentiated in
cells in which calpain activity was blocked, suggesting that
Ca
2þ-dependent activation of calpains negatively controls
KCa2.2 channel protein levels.
Analysis of mRNA levels of KCa2 channel subtypes
revealed that cortical neurons express all KCa2 subtypes:
KCa2.1, KCa2.2 and KCa2.3 (Figures 4d and e). The KCa2.3
Figure 4 GlutamateattenuatestheKCa2.2channelproteinexpression.(a)WesternblotanalysisofKCa2.2channelexpression attheindicatedtimepointsafterglutamate
exposure (20mM). Representative immunoblots are shown at the upper part of the quantiﬁed data of KCa2.2 channels analyzed from different experiments (n¼3, *Po0.05
versus non-treated PCN). (b) Neuronal cells were challenged with glutamate for 24h with or without 30min pretreatment with NS309 (50mM). Representative immunoblots
are shown at the upper part of the quantiﬁed data of KCa2.2 channels (n¼3, *Po0.05 versus non-treated PCN). (c) MTT analysis of neurons treated with NS309 (50mM)
0h, 3h, 5h and 7h after the application of glutamate (20mM). *Po0.05, **Po0.01 versus glutamate-treated neurons were considered to be signiﬁcant, ANOVA Scheffe ´’s
test. (d and e) mRNA analysis of KCa2 channel subtypes in the presence or absence of glutamate in (d) astrocyte–neuron co-culture and in (e) pure cortical neuronal cultures
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Cell Death and Diseasechannel is less abundant than KCa2.1 and KCa2.2
channel subtypes in both pure neuronal cultures (treated with
cytosine arabinoside (CAF)) and in neuron–astrocyte
co-cultures (without CAF treatment). In the pure cortical
neuronal cultures, KCa2.3 channels seemed to be expressed
at lower levels compared with neuron–astrocyte co-cultures,
suggesting that KCa2.1 and KCa2.2 channels mediated the
effects of NS309 on glutamate-induced calcium deregulation.
Glutamate did not drastically affect the KCa2.1 and KCa2.2
mRNA expression (Figures 4d and e).
KCa2 channel activator NS309 reduces ischemic brain
damage after experimental middle cerebral artery
occlusion (MCAo) in mice. To translate our results from
in vitro studies in which NS309 promoted neuroprotection
against glutamate and NMDA toxicity, we next evaluated
whether NS309 could provide neuroprotective effects in a
model of ischemic brain damage in vivo. NS309 (0.2 and
2mg/kg) was applied intraperitoneally 30min before transient
focal cerebral ischemia. Controls received vehicle, 2%
DMSO in 0.9% saline. At 24h after reperfusion, infarct
volume was 69±7mm
2 (mean±S.E.M.) in the control
group (Figures 5a and b). Non-treated animals showed
extensive ischemic injury, whereas signiﬁcant protection was
observed in NS309-treated mice (Figure 5a). Histo-
morphometrical analysis demonstrated that a single dose of
NS309 (2mg/kg) reduced the infarct volume to 45±4mm
3
compared with the vehicle-treated controls (69±7mm
2;
mean±S.E.M.; Figure 5b). The lower dose of NS309
(0.2mg/kg) did not reduce the infarct volume compared to
the controls. NS309-treated mice (2mg/kg) exhibited fast
and extensive recovery with improved neurological function
score
14 compared with controls as determined 24h after
MCAo (Figure 5c).
Discussion
In this study, we identiﬁed KCa2 channels as a promising
target to preserve [Ca
2þ]i homeostasis by counteracting
glutamate- and NMDA-induced [Ca
2þ]i deregulation and
neurotoxicity in vitro and reducing infarct development after
cerebral ischemia in vivo. In neurons, glutamate triggers
immediate increases in [Ca
2þ]i through activation of
NMDA-receptors followed by sustained disturbances in the
intracellular Ca
2þ homeostasis.
10,15 However, key regulators
ofintracellularCa
2þ homeostasisthatmayserveastargetsto
prevent such sustained glutamate toxicity in neurological
diseases have not been identiﬁed.
In this study, the KCa2 activator NS309 signiﬁcantly
attenuated [Ca
2þ]i increase when applied before the onset
of DCD, and partially contributed to [Ca
2þ]i recovery when
applied after onset of glutamate-induced DCD. Further, we
observed a close correlation of the neuroprotective potential
of KCa2 channel activation and their expression levels.
Notably, activation of the KCa2 channels preserved their
expression and their protective potential after exposure to
glutamateorNMDA.Previousreportssuggestedthatreduced
expression and functional loss of KCa2 channels were
connected to hyperexcitability in neurodegenerative pro-
cesses.
16,17 The exact mechanism of such KCa2 channel
inactivation associated with neurodegenerative processes
has not been clariﬁed so far. Our results now indicate that
Figure 5 KCa2 channel activator NS309 reduces infarct volume after transient focal cerebral ischemia. (a) Representative coronal brain slices obtained at 24h after focal
cerebral ischemia from vehiclecontrol animals (left) and mice treated with 2mg/kg NS309 right. The slices were stained with cresyl violet to identify unstained infarct areas as
marked by the dashed line. (b) Quantiﬁcation of total infarct volume determined 24h after MCAo in mice treated with 0.2 or 2mg/kg NS309 compared with vehicle-treated
controls. (c) Neuroscore measured at indicated time points after middle cerebral artery occlusion (n¼6, *Po0.05 versus non-treated mice. Mann–Whitney U-test)
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Cell Death and Diseaseactivation of NMDAR was involved in glutamate-induced
[Ca
2þ]i deregulation and subsequent delayed neuronal
death. Both, NMDA inhibitors and pharmacological activation
of KCa2 channels attenuated NMDA- and glutamate-induced
[Ca
2þ]i deregulation. In the soma of CA1 hippocampal
regions, single-channel measurements showed that L-type
calcium channel and KCa2 channels are co-localised.
9 The
contribution of voltage-dependent channels to the formation
and maintenance of DCD is unlikely, as previous experiments
usingtheL-typecalciumchannelblockernitrendipinehadlittle
effect on the delayed Ca
2þ overload once DCD had been
established.
1 However, a more recent study showed the
involvementoftransientreceptorpotentialandstore-operated
Ca
2þ channels, as the respective inhibitors 2-aminoethox-
ydiphenyl borate and La
3þ attenuated glutamate-induced
DCD.
18 In bullfrog sympathetic neurons, Ca
2þ-induced Ca
2þ
release activation prolongs Ca
2þ transients and activates BK
channels that are closely associated with N-type Ca
2þ
channels, ryanodine and KCa2 channels.
9 Ryanodine and
IP3 receptors might also be involved in DCD regulatory
processes, as application of ryanodine or caffeine was shown
to inhibit glutamate-induced DCD.
18 Removing the extracel-
lular Ca
2þ by adding the extracellular Ca
2þ chelators EDTA
or EGTA resulted in maintenance of [Ca
2þ]i. Thus, activation
of KCa2 appears to be highly efﬁcient to block pathological
Ca
2þ inﬂux from the extracellular space in the context of
glutamate excitotoxicity.
Pharmacological blockage of SERCA pumps with thapsi-
gargin or BHQ partially blocked the protective effect of NS309
on DCD. However, thapsigargin alone did not alter [Ca
2þ]i
and did not further exacerbate DCD, arguing against a major
contribution of intracellular store depletion for the observed
glutamate-induced DCD. Our observation is in agreement
with a report describing that thapsigargin did not increase
mean onset time or incidence of DCD.
18 Overall, our ﬁndings
propose that NS309-mediated KCa2 activation restores Ca
2þ
homeostasis by diminishing the Ca
2þ entry from the extra-
cellular pool but still requires functional intracellular Ca
2þ
stores for full effectiveness.
Another important ﬁnding was that NS309 preserved
the expression of KCa2 channels in neurons exposed to
glutamate. This suggests that glutamate-induced excitotoxi-
city is mediated by activation of NMDAR and concomitant
disruption of counteractive mechanisms such as KCa2
channels that disappear after the excitotoxic stimulus. This
observation may explain both, the lack of adaptation to
glutamate receptor overstimulation, and the therapeutic time
window observed for NS309. As shown in this study, NS309
mediatedneuroprotectiononlywhenappliedupto3hafterthe
onset of [Ca
2þ]i deregulation. This is in agreement with the
time window of the progressive decline in KCa2.2 channel
expression levels upon glutamate damage. After exposure to
glutamate for 5h or more, neurons expressed less KCa2.2
channels and around this time point NS309 lost the
neuroprotective potential. Apparently, such reduced KCa2.2
protein levels resulted in a failure to regulate neuronal
excitability despite increased Ca
2þ concentrations that
usually enhance the activity of the channel. Thus, neurons
undergoing delayed neuronal death after the glutamate
challenge were continuously deprived of this important feed-
back mechanism of [Ca
2þ]i, therefore showing increased
excitability and deregulated calcium homeostasis. These
ﬁndings are in agreement with the direct correlation between
the prevention of DCD and reduced KCa2.2 channel degrada-
tion.ThemechanismofKCa2channelregulationisstillunclear
but may result from Ca
2þ-dependent protein degradation or
enhanced internalization from the membrane, which might be
dependent on calpain activation.
Brief application of the glutamate receptor agonist NMDA,
on the contrary, increased KCa2.2 channel protein levels,
which was further augmented by calpain inhibition. This
suggests that activation of calcium-dependent proteases and/
or Ca
2þ-dependent gene transcription may regulate KCa2.2
channel expression physiologically. Although Ca
2þ-activated
calpains may enhance KCa2.2 degradation, nuclear factor-k B
(NF-kB) activity may enhance neuroprotective KCa2.2
expression.
19,20 It has been shown that preserved transcrip-
tional activity of NF-kB in neurons provides cerebroprotective
effectsinavariety ofdegenerativeconditions afteracutebrain
damage.
21,22 Thus, in addition to direct pharmacological
activation as achieved here with NS309, induction of KCa2
channel expression through enhanced NF-kB transcriptional
activitymaybeanadditionalstrategytoactivatethissystemof
intracellular Ca
2þ regulation.
The promising effects of KCa2 channel activation demon-
strated in vitro are also relevant for ischemic neuronal death
in vivo. Our data strongly suggest a therapeutic potential for
KCa2 channel activators in paradigms of excitotoxic neuronal
damage that contributes to infarct development after cerebral
ischemia. In line with our ﬁndings, overexpression of KCa2
channels in the dentate gyrus attenuated kainic acid-induced
hippocampalCA3 lesion, suggestingthat KCa2 channels are a
common motif of Ca
2þ autoregulation at different glutamate
receptors.
23 In vivo, the protective function of NS309 may be
extended to non-neuronal cells, as NS309 can enhance ATP-
evoked membrane hyperpolarization, along with acute
endothelial NO synthesis in isolated endothelial cells. In
addition, NS309 was shown to augment the acetylcholine-
induced vasodilatation in small-resistance arterioles that
might improve the recovery of damaged tissue.
24 It is
interesting to note that two FDA-approved drugs, namely,
riluzole(usedinthetreatmentofamyotrophiclateralsclerosis)
and chlorzoxazone (used as central myorelaxant)
25 have
been reported to enhance the activity of KCa2 channels,
26
suggesting a clinical relevance of the present ﬁndings on
neuroprotection mediated by KCa2 channel activation in vitro
and in vivo. For example, KCa2 channel activation may
signiﬁcantly contribute to the reported effects of the neuro-
protectant riluzole, that is, that it inhibits the release of
glutamate from nerve terminals, modulates NMDA receptors
and reduces neuronal excitability.
27
In conclusion, our data suggest that activation of KCa2
channels promotes neuroprotection in vitro and in vivo by
reducing glutamate- and NMDA-induced [Ca
2þ]i deregula-
tion. KCa2 channels may, therefore, have a major role in the
regulatory feedback loop that interrupts the glutamate-
triggered neuronal hyperexcitability, progressive disturbance
of Ca
2þ homeostasis and excitotoxic neuronal death.
Accordingly, KCa2 channels may serve as novel therapeutic
targets to prevent intracellular Ca
2þ overload under
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Materials and Methods
Primarycorticalneuronculture. Primarycorticalneuronswereplatedata
density of 16 10
3 cells/well (96 well plates) and 3 10
5 cells/well (6 well plates)
on polyethyleneimine pre-coated plates. Neurobasal medium supplemented with
5mMHEPES,1.2mMglutamine,2%(v/v)B27supplement(20ml/l)andgentamicin
(0.1mg/ml) was used as a culture medium. Neurons were treated with the KCa2
channel activator NS309, the KCa2 channel blocker NS8593 or apamin for the
indicated time periods. On the basis of previous kinetic studies, NS309 was used at
a concentration of 50mM.
19
Evaluation of cell viability. Neuronal viability was determined by the
colorimetric MTT assay. The absorbance of each well was determined with an
automated FLUOstar Optima reader (BMG Labtech, Offenburg, Germany) at
570nm with a reference ﬁlter at 630nm.
Calcium measurements in single neurons using calcium
imaging. Primary cortical cells were incubated with 2mM FURA-2 AM for
30min at 371C in HEPES-ringer buffer. Drugs were diluted in HEPES-ringer buffer
(20mM glutamate, 500mM NMDA, 50mM NS309, 50mM NS8593, 1mM apamin,
25mM MK801, 4mM EDTA and 4mM EGTA). Fluorescence intensities from single
cellsexcitedatthetwowavelengths(F340andF380)wererecordedseparatelyand
combined (ﬂuorescence ratio: r¼F340/F380) after background subtraction
(ﬂuorescence of a cell-free area).
Protein analysis. Primary cortical neurons were lysed in 20mM Tris, 150mM
NaCl,1mM EDTA,1mM EGTA,1% TritonX,2.5mM sodium pyrophosphate, 1mM
sodium orthovanadate, complete mini protease inhibitor cocktail tablet and
phosphatase inhibitor cocktail 1 and 2. The membranes were incubated
overnight with primary antibodies (1:3000; rabbit anti-KCa2.2
28 channel at 41C
and afterwards with peroxidase-conjugated secondary antibodies (1:2500).
RT-PCR. Total RNA was extracted using the NucleoSpin RNA II kit (Macherey-
Nagel GmbH & Co. KG, Du ¨ren, Germany). RT reactions were conducted in a
thermocyclerwithsettingat421Cfor 30min.Ampliﬁcationsusingspeciﬁcprimers
29
by PCRwere carriedout for 27 or 30 cyclesat varioussteps:(1) denaturingat 951C
for 4min; (2) 941C for 30s; (3) annealing temperature (Tm) for 30s, depending on
the KCa2 isoform of interest; and (4) extension at 721C for 30s. The ﬁnal extension
step was set to 721C for 5min. The Tm for KCa2.1 was 631C, 57,31C for KCa2.2 and
611C for KCa2.3.
Transient focal cerebral ischemia. All animal experiments were
conducted according to the guidelines of Government of Upper Bavaria. Male
C57BL/6 mice were subjected to 60 min transient MCAo by an intraluminal ﬁlament
as previously described.
14 Mice were killed and brains were removed and frozen in
powdered dry ice 24h after reperfusion. Infarct volume was calculated by
multiplying the infarct areas with the distance between sections. NS309 was
administered 30min before MCAo by intraperitoneal injection (100ml per 20g) at a
concentration of 0.2mg/kg and 2mg/kg. Saline (0.9%) with 2% DMSO was used
as vehicle.
Statistical analysis. All data are given as means±S.D. For statistical
comparisons between two groups, Student’s t-test was used; multiple comparisons
were performed by ANOVA followed by Scheffe ´’s post hoc test. Calculations were
performed with the Winstat standard statistical software package. For the MCAo
experiments we have used the Mann–Whitney U-test for the analysis of differences
between groups and also by ANOVA followed by Scheffe ´’s or Tukey’s as post hoc
analysis. A statistically signiﬁcant difference was assumed at Po0.05.
Othermethods,includinghippocampalslicepreparation,patch-clamprecordings
and data sanalysis were carried out as described in Andres et al.
29,L iet al.
30,
Pedarzani et al.
31 and Landshamer et al.
32 Further details are provided in
Supplementary Materials and Methods.
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